Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 2/20 | 0.64 |
| ▸ | CCND1 | P24385 | 2/20 | 0.64 |
| ▸ | GABRA1 | P14867 | 7/20 | 0.60 |
| ▸ | GABRG2 | P18507 | 7/20 | 0.60 |
| ▸ | GABRB3 | P28472 | 7/20 | 0.60 |
| ▸ | GABRA5 | P31644 | 7/20 | 0.60 |
| ▸ | GABRA3 | P34903 | 7/20 | 0.60 |
| ▸ | GABRA2 | P47869 | 7/20 | 0.60 |
| ▸ | PARP1 | P09874 | 3/20 | 0.57 |
| ▸ | GABRP | O00591 | 4/20 | 0.53 |
| ▸ | GABRD | O14764 | 4/20 | 0.53 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.53 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.53 |
| ▸ | GABRE | P78334 | 4/20 | 0.53 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.53 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.53 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.53 |
| ▸ | GABRQ | Q9UN88 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29546163 | 1.00 | CDK4 (0.64) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL16547003 | 0.91 | CDK4 (0.62) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL28846510 | 0.91 | GABRA1 (0.59) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL30805677 | 0.91 | GABRA1 (0.59) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL18042294 | 0.89 | GABRA1 (0.60) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL19988704 | 0.84 | GABRA1 (0.63) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL30166687 | 0.81 | CDK4 (0.56) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL13556881 | 0.80 | GABRA1 (0.58) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL19988566 | 0.78 | MAP3K11 (0.53) | CDK4CCND1GABRA1GABRG2GABRB3 | |
| SCHEMBL23099057 | 0.76 | KIF11 (0.56) | CDK4CCND1GABRA1GABRG2GABRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0757559-A4 | COMPOSITION FOR DELIVERY OF TOXIC RADIOISOTOPES TO THE CELL NUCLEUS AND USE | MOLECULAR MEDICINE CENTER (US) | 1999-06-23 | — | — | EP | claimed |
| EP-0757559-A1 | COMPOSITION FOR DELIVERY OF TOXIC RADIOISOTOPES TO THE CELL NUCLEUS AND USE | CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY (US) | 1997-02-12 | — | — | EP | claimed |
| WO-1995029707-A1 | COMPOSITION FOR DELIVERY OF TOXIC RADIOISOTOPES TO THE CELL NUCLEUS AND USE | CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY (US) | 1995-11-09 | — | — | WO | claimed |
| US-20190011433-A1 | CELL CO-CULTURE SYSTEMS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2019-01-10 | — | — | US | disclosed |
| US-20130274142-A1 | Cell Co-Culture Systems and Uses Thereof | DANA-FARBER CANCER INSTITUTE, INC. | 2013-10-17 | — | — | US | disclosed |
| US-8080531-B2 | Methods for modulating checkpoint activation through TopBP1 | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2011-12-20 | — | — | US | disclosed |
| US-20100255999-A1 | Cell Co-Culture Systems and Uses Thereof | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2010-10-07 | — | — | US | disclosed |
| EP-2115456-A2 | CELL CO-CULTURE SYSTEMS AND USES THEREOF | Dana-Farber Cancer Institute, Inc. (US) | 2009-11-11 | — | — | EP | disclosed |
| US-20090098111-A1 | Methods for modulating checkpoint activation through TopBP1 | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2009-04-16 | — | — | US | disclosed |
| WO-2008095165-A2 | CELL CO-CULTURE SYSTEMS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2008-08-07 | — | — | WO | disclosed |
| US-20080119685-A1 | Methods for modulating checkpoint activation through TopBP1 | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2008-05-22 | — | — | US | disclosed |
| US-20050227266-A1 | Biomarker:compound correlations in cancer diagnosis and therapy | APPLIED GENOMICS, INC. | 2005-10-13 | — | — | US | disclosed |
| EP-0882037-B1 | ARTEMISININ DIMER COMPOUNDS HAVING ANTICANCER ACTIVITY | HAUSER CHEMICAL RES INC (US) | 2001-09-12 | — | — | EP | disclosed |
| US-6057348-A | INHIBITOR OF CELL GROWTH AND MITOSIS | OREGON STATE UNIVERSITY (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0882037-A4 | ARTEMISININ DIMER COMPOUNDS HAVING ANTICANCER ACTIVITY | HAUSER CHEMICAL RES INC (US) | 2000-01-19 | — | — | EP | disclosed |
| US-5856351-A | Artemisinin dimer compounds having anticancer activity | WELLS FARGO BANK, N.A. | 1999-01-05 | — | — | US | disclosed |
| EP-0882037-A1 | ARTEMISININ DIMER COMPOUNDS HAVING ANTICANCER ACTIVITY | HAUSER CHEMICAL RESEARCH, INC. (US) | 1998-12-09 | — | — | EP | disclosed |
| US-5677468-A | Artemisinin dimer compounds having anticancer activity | HAUSER, INC. (US) | 1997-10-14 | — | — | US | disclosed |
| WO-1997001548-A1 | ARTEMISININ DIMER COMPOUNDS HAVING ANTICANCER ACTIVITY | HAUSER CHEMICAL RESEARCH, INC. (US) | 1997-01-16 | — | — | WO | disclosed |
| WO-1995009630-A1 | COMPOUNDS EXHIBITING ANTIPROLIFERATIVE ACTIVITY AGAINST CELLS | THE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIVERSITY (US) | 1995-04-13 | — | — | WO | disclosed |